CSIMarket
 


Calithera Biosciences Inc   (CALA)
Other Ticker:  
 

Cumulative Calithera Biosciences Inc 's Leverage Ratio for Trailing Twelve Months Period

CALA's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

CALA Leverage Ratio for Trailing Twelve Months Period

(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
Y / Y Equity Growth 143.28 % -64.54 % -57.54 % - -91.81 %
Y / Y Total Liabilities Growth -85.31 % -31.23 % -30.57 % 223.49 % 142.82 %
Leverage Ratio for Trailing Twelve Months Period 1.05 1.95 1.18 0.86 0.4
Total Ranking # 2308 # 3056 # 2416 # 2080 # 1132
Seq. Equity Growth -22.72 % -25.14 % - - -88.74 %
Seq. Total Liabilities Growth -22.54 % 3.76 % -80.69 % -5.33 % 262.49 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2022
On the trailing twelve months basis Due to debt repayement of -22.54% Calithera Biosciences Inc decreased Leverage Ratio for Trailing Twelve Months Period in the IV. Quarter to 1.05, above Calithera Biosciences Inc 's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 269 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Calithera Biosciences Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are CALA's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 270
Sector # 493
S&P 500 # 1080


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
1.95 0.4 0.13
(Sep 30 2022)   (Dec 31 2018)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2022, within Major Pharmaceutical Preparations Industry Leverage Ratio for Trailing Twelve Months Period
Ionis Pharmaceuticals Inc  2.73 
Seres Therapeutics Inc   2.62 
Calliditas Therapeutics Ab  2.58 
Calithera Biosciences Inc   2.47 
Societal Cdmo Inc   2.47 
Phibro Animal Health Corporation  2.41 
Aslan Pharmaceuticals Limited  2.37 
Journey Medical Corporation  2.30 
Maravai Lifesciences Holdings Inc   2.28 
Nls Pharmaceutics Ltd   2.23 
Apellis Pharmaceuticals Inc   2.22 
Paxmedica Inc   2.21 
Jazz Pharmaceuticals Plc  2.19 
Oncosec Medical Incorporated  2.17 
Allarity Therapeutics Inc   2.15 
Mei Pharma Inc   2.15 
Bristol myers Squibb Company  2.10 
Zoetis Inc   2.09 
Celularity Inc   2.05 
Bellicum Pharmaceuticals Inc   1.99 
Evoke Pharma Inc   1.95 
Fortress Biotech Inc   1.95 
Effector Therapeutics Inc   1.92 
Axsome Therapeutics Inc   1.85 
Pieris Pharmaceuticals Inc   1.83 
Avid Bioservices Inc   1.74 
Aveo Pharmaceuticals Inc   1.73 
Lifecore Biomedical Inc   1.70 
Kineta Inc   1.67 
Neptune Wellness Solutions Inc   1.67 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com